Surveillance Versus Treatment of Unruptured Intracranial Aneurysms of Fortuitous Discovery
A legfontosabb adatok
- Ki végzi
- Assistance Publique - Hôpitaux de Paris
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 600 fő, tervezett
- Kezdés
- 2026. nov.
- Várható befejezés
- 2033. máj.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Clinical and imaging surveillance
- Endovascular or neurosurgical aneurysm treatment
- A regiszteradat frissítve
- 2026. szeptember 14.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a brain aneurysm (a bulge in a brain artery) that has not burst and was found by chance. It compares regular scans with no initial treatment against treating the aneurysm right away.
- Életkor
- 35 to 75 years
- Nem
- All sexes
- A betegség stádiuma
- Unburst aneurysm inside the skull lining (intradural), confirmed on CT angiography or conventional cerebral angiography. Its largest diameter is between 2 mm and 7.9 mm. People with more than one aneurysm can join if at least one meets all criteria and none measures 8 mm or more.
- Korábbi kezelés
- No earlier treatment for a brain aneurysm, burst or not.
A részvétel fő kizáró okai
- A bleed around the brain (subarachnoid haemorrhage) in the past with no known cause, or an aneurysm found during a recent sudden severe or effort-related headache.
- Aneurysm that cannot be treated by surgery or through the blood vessels, or a serious reason anaesthesia cannot be used.
- Some disability already (mRS score of 2 or more), or an illness that limits life expectancy to less than 3 years.
- Certain aneurysm shapes or locations, or an aneurysm linked to a brain AVM; polycystic kidney disease, inherited connective tissue disorders or sickle cell disease.
- Pregnancy or wish to get pregnant, allergy to iodine contrast dye, or severe kidney problems (GFR < 30 mL/min/1.73m2).
A regiszter feltételei, szó szerint
Mind a 23 feltétel megnézéseKevesebb
Ki vehet részt
- UIA (Unruptured Intracranial Aneurysms) located in an intradural position, with confirmed presence on CT (Computed Tomography) angiography or conventional cerebral angiography
- Largest diameter between 2 mm and 7.9 mm inclusive in height or width (excluding oblique measurements)
- Patients with one or more UIAs, provided that at least one aneurysm (index aneurysm) fulfills all inclusion criteria and is selected for study evaluation
- Patients aged ≥ 35 years to 75 years
- Patients must have signed informed consent
- Patients must be affiliated with the French healthcare system
Ki nem vehet részt
- Aneurysms deemed inoperable by endovascular or surgical techniques, and patients with absolute contraindications to anaesthesia
- Patients with a history of prior treatment for a cerebral aneurysm (ruptured or unruptured)
- Patients with a disease reducing life expectancy to less than 3 years
- History of unexplained SAH (Subarachnoid Haemorrhage)
- Patients with autosomal dominant polycystic kidney disease (ADPKD), hereditary connective tissue disorders (HCTDs), or sickle cell disease (SCD)
- Allergy to iodinated contrast material
- Severe renal impairment (Glomerular Filtration Rate (GFR) < 30 mL/min/1.73m2)
- Patients with a mRS score of ≥2
- UIA discovered in the context of a recent thunderclap or exertional headache
- Fusiform, mycotic, or intracavernous UIAs
- Infundibulum of the posterior communicating artery (PcomA) and choroidal artery
- Very distal saccular UIAs: A3/A4, M3/M4, P3/P4
- UIA associated with brain AVM (Arteriovenous Malformation)
- Patients presenting with multiple UIAs in whom at least one aneurysm measures ≥ 8 mm, in order to avoid inclusion of patients at higher overall rupture risk not compatible with the study population
- Pregnancy or a desire for pregnancy during the study period
- Current participation in another interventional research study
- Patients likely to fail to attend follow-up visits or adhere to the protocol
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 35 és 75 év között vagy?
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to determine whether a watchful waiting strategy with imaging surveillance is superior to immediate aneurysm treatment in adults with incidentally discovered unruptured intracranial aneurysms (UIAs).
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
* Does watchful waiting reduce the risk of clinically significant neurological disability compared with immediate treatment? * How do the two strategies compare in terms of aneurysm rupture, treatment-related complications, quality of life, anatomical outcomes, and healthcare costs?
Researchers will compare two management strategies:
* Immediate selective treatment of the aneurysm (endovascular or neurosurgical treatment according to standard practice). * Watchful waiting with regular clinical and imaging follow-up and no initial aneurysm treatment.
Participants will:
* Be randomly assigned to either immediate treatment or watchful waiting. * Undergo routine clinical assessments and annual brain imaging for at least 42 months. * Complete quality-of-life questionnaires (EQ-5D-5L) at baseline and annually during follow-up. * Participate in annual telephone follow-up assessments, including evaluation of functional outcome using the modified Rankin Scale (mRS). * Undergo a blood or urine pregnancy test at enrollment if they are women of childbearing potential.
The study includes adults aged 35 years or older with incidentally discovered, non-infectious, intradural saccular UIAs measuring between 2.0 mm and 7.9 mm and no history of subarachnoid hemorrhage. The primary objective is to compare the impact of the two management strategies on neurological dependency during follow-up.
A vizsgálat 2 csoportja
- Watchful waiting strategyA vizsgált kezelés
Participants randomized to the watchful waiting strategy will receive no immediate preventive treatment of the unruptured intracranial aneurysm. This strategy consists of initial non-interventional management with standard clinical follow-up and annual brain imaging according to standard care. In the case of patients with multiple aneurysms, all aneurysms will be monitored under the same watchful waiting protocol. Selective treatment is not performed at baseline, but may be considered during follow-up if clinically indicated.
Kezelés: Clinical and imaging surveillance
- Intervention strategyMár használt kezelés, összehasonlításként
Participants undergo immediate preventive treatment of the incidentally discovered unruptured intracranial aneurysm using standard endovascular or neurosurgical techniques. Post-procedural follow-up is conducted according to standard care (clinical follow-up and annual brain imaging).
Kezelés: Endovascular or neurosurgical aneurysm treatment
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Surveillance Versus Treatment of Unruptured Intracranial Aneurysms of Fortuitous Discovery : a Randomized Controlled Trial STAF Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07817511: ki vehet részt
- A regiszteradat frissítve
- 2026. szeptember 14.